supraespinatus syndrome
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Men and women aged or older than 18 years; complaint of persistent pain in one or both shoulders for the past 3 months; clinical and imaging diagnosis of tendinopathy of any of the rotator cuff muscles
Exclusion criteria
Exclusion criteria: People with absolute or relative contraindication to MEP ( Percutaneous Microelectrolysis); diagnosis of rheumatologic, systemic or neurodegenerative diseases causing shoulder pain such as rheumatoid arthritis, sickle anemia or stroke hemiparesis; shoulder surgery history; history of corticosteroid infiltration treatment performed within the last 2 months; having other pathological conditions of a traumatic-orthopedic nature such as adhesive capsulitis, traumatic lesions of the labrum and fractures in the shoulder complex
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcome 1. The pain intensity of all participants will be measured at the beginning and at the end of the 8 weeks of the study by the Numerical Pain scale. The Numerical Pain Scale is a horizontal bar, ranging from 0 to 0 points. For its application, the evaluator will verbally explain to the participant that zero indicates the absence of pain, and ten represents unbearable pain. Thus, the participant must indicate to the evaluator which score represents the intensity of pain in the shoulder region. The Numerical Pain Scale has test-retest reliability, with an Intraclass Correlation Coefficient (ICC) of 0.74 in participants with shoulder pain and an MDCI ( Minimal Clinically Important Difference) of 1.4. What is expected is that after the 8 weeks of intervention there will be an improvement (reduction) in pain represented by the greater decrease in the Numerical Pain Scale score in the experimental group, but the tests of statistical analysis will tell if this decrease has statistical significance or not. . ;Primary outcome 2. Shoulder function will be assessed before and after 8 weeks of treatment using the Shoulder Pain and Disability Index Questionnaire (SPADI). The ability of workers to perform daily tasks will be evaluated using the Shoulder Pain and Disability Index (SPADI) Questionnaire, validated in Brazil. This questionnaire is specific for assessing the intensity of shoulder pain and disability associated with routine activities in the past week. The questions are directed to the affected arm and are composed of 13 items. The first eight questions are related to disability and the next 5 questions are about shoulder pain. Each item has a score that varies from 0 to 10, and at the end, the result of the questionnaire can range from 0 to 100 points, with 100 being the worst condition. Regarding reliability, the SPADI test-retest varied the ICC (Confidence Coefficient Interval) from 0.90 to 0.94 and the MDCI ( Minimal clinically important difference) | — |
Secondary
| Measure | Time frame |
|---|---|
| At the end of the 8 weeks of interventions, all 46 participants will be assessed using the Perception of Global Effect Scale. Perception of Global Effect Scale: This questionnaire checks the patient's global impression of current recovery, comparing the onset of symptoms and the health condition at the time of application of the questionnaire, its application is performed only at the end of the intervention. The scale is composed of 11 points, starting at -5 (much worse) going through 0 (noticed changes) and ending at 5 (completely recovered). The test-retest reliability was (Confidence Coefficient Interval) ICC=0.90 It is expected that after the 8 weeks of intervention, the experimental group will have a higher score than the control group and that it will be 5 points or close to that. | — |
Countries
Brazil
Contacts
Hospital Universitário Alcides Carneiro